Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Massively Scalable Platform for Dual-Mode Discovery of Anti-Amyloid Drugs

Project description

Speeding up the search for anti-amyloid therapies

Amyloid aggregates damage cells and disrupt normal tissue function. They are a hallmark of Alzheimer’s and Parkinson’s. Unfortunately, the development of effective treatments has been slowed. A major challenge in amyloid research lies in capturing the earliest stages of aggregate formation, where transient, heterogeneous species emerge and evolve before conventional experimental methods can resolve them. To address this, the ERC-funded AMALIA project is creating a scalable drug-discovery platform to detect and test compounds targeting amyloid aggregation. It combines two complementary high-throughput assays, making it easier and more cost-effective to identify promising anti-amyloid therapies across multiple disease targets. The goal is to accelerate the development of new treatments.

Objective

Amyloids are protein aggregates that underlie Alzheimer’s, Parkinson’s, and other devastating diseases, yet effective therapies remain elusive. A key bottleneck is our limited ability to study and target the earliest steps of amyloid formation, which are difficult to probe with existing approaches and poorly suited for large-scale discovery. AMALIA addresses this gap by establishing a dual, massively scalable platform for anti-amyloid drug discovery, combining complementary assays that target aggregation through distinct mechanisms. This project will validate AMALIA as a scalable and versatile platform for anti-amyloid drug discovery and downstream translation. Enabling parallel, cost-effective discovery across multiple amyloid targets, AMALIA has the potential to fundamentally change how anti-amyloid therapeutics are developed.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-POC

See all projects funded under this call

Host institution

FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA
Net EU contribution
€ 150 000,00
Address
CARRER BALDIRI REIXAC PLANTA 2A 10-12
08028 Barcelona
Spain
Region
Este Cataluña Barcelona
Activity type
Research Organisations
Links
Total cost
No data

Beneficiaries (1)